Corrigendum to "Interleukin 10 deficiency exacerbates halothane induced liver injury by increasing interleukin 8 expression and neutrophil infiltration" [Biochem. Pharmacol 77 (2009) 277-284] (DOI:10.1016/j.bcp.2008.09.028);Interleukin 10 deficiency exacerbates halothane induced liver injury by increasing interleukin 8 expression and neutrophil infiltration

Biochemical Pharmacology

Volumn 77, Issue 2, 2009, Pages 277-284

  Feng, Dechun ^a   Wang, Ying ^b   Xu, Yan ^a   Luo, Qingqiong ^b   Lan, Bin ^a   Xu, Lingyun ^a,b  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Halothane; IL 10; IL 8; Liver injury; Neutrophil

Indexed keywords

ALANINE AMINOTRANSFERASE; CHEMOATTRACTANT; HALOTHANE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; RECOMBINANT INTERLEUKIN 10; STAT1 PROTEIN; STAT3 PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GEL MOBILITY SHIFT ASSAY; IMMUNOFLUORESCENCE; KNOCKOUT MOUSE; LIVER INJURY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

EID: 57249103376     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.02.003     Document Type: Erratum

References (36)

1. Ibanez L., Perez E., Vidal X., and Laporte J.R. Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. J Hepatol 37 (2002) 592-600
2. Temple R.J., and Himmel M.H. Safety of newly approved drugs: implications for prescribing. Jama 287 (2002) 2273-2275
3. You Q., Cheng L., Reilly T.P., Wegmann D., and Ju C. Role of neutrophils in a mouse model of halothane-induced liver injury. Hepatology 44 (2006) 1421-1431
4. Wright R., Eade O.E., Chisholm M., Hawksley M., Lloyd B., Moles T.M., et al. Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet 1 (1975) 817-820
5. Farrell G.C., Frost L., Tapner M., Field J., Weltman M., and Mahoney J. Halothane-induced liver injury in guinea-pigs: importance of cytochrome P450 enzyme activity and hepatic blood flow. J Gastroenterol Hepatol 11 (1996) 594-601
6. Lind R.C., Gandolfi A.J., and Hall P.D. Age and gender influence halothane-associated hepatotoxicity in strain 13 guinea pigs. Anesthesiology 71 (1989) 878-884
7. Bourdi M., Masubuchi Y., Reilly T.P., Amouzadeh H.R., Martin J.L., George J.W., et al. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35 (2002) 289-298
8. Bourdi M., Eiras D.P., Holt M.P., Webster M.R., Reilly T.P., Welch K.D., et al. Role of IL-6 in an IL-10 and IL-4 double knockout mouse model uniquely susceptible to acetaminophen-induced liver injury. Chem Res Toxicol 20 (2007) 208-216
9. Nagaki M., Naiki T., Brenner D.A., Osawa Y., Imose M., Hayashi H., et al. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB. Hepatology 32 (2000) 1272-1279
10. Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol 2 (2005) 92-100
11. Gao B., Jeong W.I., and Tian Z. Liver: An organ with predominant innate immunity. Hepatology 47 (2008) 729-736
12. Santucci L., Fiorucci S., Chiorean M., Brunori P.M., Di Matteo F.M., Sidoni A., et al. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology 111 (1996) 736-744
13. Louis H., Van Laethem J.L., Wu W., Quertinmont E., Degraef C., Van den Berg K., et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 28 (1998) 1607-1615
14. Yoshidome H., Kato A., Edwards M.J., and Lentsch A.B. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology 30 (1999) 203-208
15. Jaeschke H., Farhood A., and Smith C.W. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. Faseb J 4 (1990) 3355-3359
16. Jaeschke H., Farhood A., Bautista A.P., Spolarics Z., Spitzer J.J., and Smith C.W. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 17 (1993) 915-923
17. Hewett J.A., Schultze A.E., VanCise S., and Roth R.A. Neutrophil depletion protects against liver injury from bacterial endotoxin. Lab Invest 66 (1992) 347-361
18. Chen C.C., and Manning A.M. TGF-beta 1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine 8 (1996) 58-65
19. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209-1220
20. Ehrlich L.C., Hu S., Peterson P.K., and Chao C.C. IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation. Neuroreport 9 (1998) 1723-1726
21. Yoshimura T., Matsushima K., Tanaka S., Robinson E.A., Appella E., Oppenheim J.J., et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84 (1987) 9233-9237
22. Beaubien B.C., Collins P.D., Jose P.J., Totty N.F., Hsuan J., Waterfield M.D., et al. A novel neutrophil chemoattractant generated during an inflammatory reaction in the rabbit peritoneal cavity in vivo. Purification, partial amino acid sequence and structural relationship to interleukin 8. Biochem J 271 (1990) 797-801
23. Jose P.J., Collins P.D., Perkins J.A., Beaubien B.C., Totty N.F., Waterfield M.D., et al. Identification of a second neutrophil-chemoattractant cytokine generated during an inflammatory reaction in the rabbit peritoneal cavity in vivo. Purification, partial amino acid sequence and structural relationship to melanoma-growth-stimulatory activity. Biochem J 278 Pt 2 (1991) 493-497
24. Pease J.E., and Sabroe I. The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy. Am J Respir Med 1 (2002) 19-25
25. Murphy P.M., and Tiffany H.L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253 (1991) 1280-1283
26. Holmes W.E., Lee J., Kuang W.J., Rice G.C., and Wood W.I. Structure and functional expression of a human interleukin-8 receptor. Science 253 (1991) 1278-1280
27. Chuntharapai A., and Kim K.J. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol 155 (1995) 2587-2594
28. Roebuck K.A. Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 19 (1999) 429-438
29. Hoffmann E., Dittrich-Breiholz O., Holtmann H., and Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol 72 (2002) 847-855
30. Allen M., Svensson L., Roach M., Hambor J., McNeish J., and Gabel C.A. Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med 191 (2000) 859-870
31. Kontoyiannis D., Kotlyarov A., Carballo E., Alexopoulou L., Blackshear P.J., Gaestel M., et al. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. Embo J 20 (2001) 3760-3770
32. Hong F., Jaruga B., Kim W.H., Radaeva S., El-Assal O.N., Tian Z., et al. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110 (2002) 1503-1513
33. Siebler J., Wirtz S., Klein S., Protschka M., Blessing M., Galle P.R., et al. A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell-mediated liver inflammation. Hepatology 38 (2003) 1573-1580
34. Kim W.H., Hong F., Radaeva S., Jaruga B., Fan S., and Gao B. STAT1 plays an essential role in LPS/d-galactosamine-induced liver apoptosis and injury. Am J Physiol Gastrointest Liver Physiol 285 (2003) G761-G768
35. Cressman D.E., Diamond R.H., and Taub R. Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology 21 (1995) 1443-1449
36. Shen X., Hong F., Nguyen V.A., and Gao B. IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3. FEBS Lett 480 (2000) 132-136